v3.22.2.2
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 09, 2021
Mar. 16, 2020
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Class of Stock [Line Items]              
Preferred stock, shares authorized     1,000,000   1,000,000   1,000,000
Common stock, outstanding     139,900,000 139,900,000 139,900,000 139,900,000 139,900,000
Common stock, issued     139,900,000 139,900,000 139,900,000 139,900,000 139,900,000
Number of shares issued     0 0 0 0  
Options exercise price $ 0.0001            
Option grant value, per option $ 0.5625            
Option grant value             $ 1,406,250
Stock compensation expense     $ 0 $ 0 $ 0 $ 0  
Chief Financial Officer [Member]              
Class of Stock [Line Items]              
Number of stock options to purchase common stock 2,500,000            
Series A Preferred Stock [Member]              
Class of Stock [Line Items]              
Preferred stock, voting rights   the Series A Preferred Stock as a series of preferred stock of the Company. 1,000 shares of Series A Preferred Stock are authorized in the Certificate. The Series A Preferred Stock has voting rights equivalent to three times the total voting power of the total common stock outstanding at any time. The Series A Preferred Stock has no transfer rights, no conversion rights, no dividends, and no liquidation preference.          
Preferred stock, shares authorized   1,000 1,000   1,000   1,000
Preferred stock, issued     1,000   1,000   1,000
Preferred stock, outstanding     1,000   1,000   1,000
Series A Preferred Stock [Member] | Mr James Owens [Member]              
Class of Stock [Line Items]              
Preferred stock, issued     1,000   1,000    
Preferred stock, outstanding     1,000   1,000